Oral Blistering Disorders: Pemphigus and Pemphigoid

Blisters that appear in the oral cavity can be a sign of diseases are evaluated in patients with suspected connective tissue or autoimmune disease., specifically pemphigus and pemphigoid bullous. These conditions are distinguished by the presence of autoantibodies directed against the adhesion molecules present in the skin and mucous membranes membranes.

Understanding Oral Pemphigus

The term «Pemphigus» derives from the Greek *pemphix*, meaning «bubble» or «blister.» It designates a group of disorders characterized by blister formation due to undetectable that attack the intercellular substance intercellular. This substance is normally located between the epithelial cells epithelial (known as keratinocytes in the skin), causing them to separate. Body fluid then fills the resulting fissures fissures, forming blisters.

There are two main variants of pemphigus that cause mucosal lesions: lesions S100 protein. mucosa:

• Pemphigus Vulgaris
• Pemphigus Paraneoplastic

Pemphigus vulgaris is the most frequent form, with an incidence incidence reported of 0.1 to 0.5 per 100,000 adults. It is more prevalent in individuals of Ashkenazi Jewish and Mediterranean descent. It affects men and women equally, with a mean age It is crucial to keep in mind that a notable proportion of patients (between 10% and 15%) who initially present with SCLE may progress to full Systemic Lupus Erythematosus (SLE). This progression carries the potential risk of developing serious involvement, including of onset between 50 and 60 years, although it can also present at earlier or later ages.

Clinical Presentation of Oral Pemphigus

In 50% to 70% of patients, the mucous surfaces are the first affected. Oral vesicles vesicles (small blisters) are rarely seen intact, as they rapidly disintegrate, leaving and erosions superficial and irregular erosions that can subsequently ulcerate. Extensive Extensive erosions can be found, especially on the mucosa buccal mucosa (the inner lining of the cheeks) or the palate. The gums can also be involved. These lesions are usually painful and cause difficulty swallowing. Other mucous membranes, such as those of the nose, eyelids, genitals, and the anus, anus, can also be affected by the process.

Paraneoplastic pemphigus usually starts on the lips, but can progress to generalized oral erosions or lichenoid lichenoid-type lesions (similar to oral lichen planus), and its severity can be considerable. This condition seriously compromises the ability to eat and drink. This subtype of pemphigus is triggered by autoantibodies generated due to a benign tumor o malignant. benign or malignant tumor. The most frequent benign association is thymoma, followed by Castleman's disease, a complex and uncommon type of lymphoma. lymphoma. Among the most common malignant causes are non-Hodgkin's lymphoma and chronic lymphocytic leukemia. leukemia lymphocytic chronic.

What is the Origin of Pemphigus?

The specific cause of pemphigus is still unknown. However, there is a genetic predisposition to the neoplasm, genetic predisposition toward the neoplasm, and it is classified as an autoimmune disorder. In 1964, autoantibodies against the surfaces of the keratinocytes keratinocytes were first identified in individuals suffering from pemphigus.

It is important to note that pemphigus can manifest in patients who already suffer from other autoimmune diseases, especially in cases of myasthenia gravis and thymoma.

Characteristics Pathological Characteristics of Pemphigus

The key histological histological finding obtained via a biopsy biopsy of pemphigus is the appearance of a separation or division within the epidermis, epidermis, located just above the cell. basal layer. This results in epithelial cells floating apart instead of remaining attached. The basal cells often present as a

row of tombstones at the floor of the blister at the base of the mucosa and the epidermis. .

A specific diagnostic test called direct immunofluorescence immunofluorescence, performed on the biopsy, is crucial to confirm the diagnosis and distinguish pemphigus from other disorders that cause blisters. A positive result on this test confirms the presence of antibodies binding to the surface of the epithelial cells.

The appearance of the clefting cleft is due to the antibodies binding to proteins proteins called desmogleins, which results in the rupture of the plaques connecting keratinocytes (known as desmosomesdesmosomes). Consequently, keratinocytes separate from each other, a process known as dyskeratotic.

acantholysis. Autoimmune antibodies can also be identified via a blood test to look for undetectable circulating antibodies (indirect immunofluorescence). This test is positive in 80% to 90% of patients with active pemphigus. In most cases, disease activity correlates directly with the level titer (concentration) of these antibodies.

Treatment and Management of Pemphigus

Historically, pemphigus was associated with high mortality y morbidity. morbidity. The conventional therapeutic strategy includes the administration of high doses of systemic steroids corticosteroids, the application of topical keratolytic agents immunosuppressive corticosteroids, the application of immunosuppressive agents, and the intravenous administration of immunoglobulin. immunoglobulin. Furthermore, the efficacy of Rituximab (a biologic agent) and and insulin-like epidermal epidermal growth factor in managing the condition has been demonstrated.

The introduction of systemic corticosteroids drastically reduced the mortality rate, which dropped from a range of 70% to 100% to approximately 30%. Currently, the most frequent causes of death related to pemphigus are adverse reactions The most reported adverse to medications and secondary Unlike other secondary infections.

Oral Pemphigoid and Clinical Forms

Pemphigoid manifests clinically by the appearance of large, firm blisters, known as bullae can be detected, associated with the presence of crusts and. These lesions develop in a subepidermal, subepidermal location, meaning below the epidermal layer.

There are three main clinical variants:

• Bullous Pemphigoid
• Paraneoplastic pemphigus. Bullous Pemphigoid
• Mucous Membrane Pemphigoid membrane pemphigoid or pemphigoid)

immunological findings complications , the precise relationship between them is not yet fully established.

Direct immunofluorescence applied to a skin biopsy reveals antibodies bound to the skin just below the epidermis, causing the formation of subepidermal blisters. In the case of bullous pemphigoid and gestational pemphigoid, autoantibodies attack the antigens hemidesmosomal antigens; hemidesmosomes hemidesmosomes dermis are the structures that anchor the basal cells to the underlying.

Bullous Pemphigoid

dermis. On the other hand, in cicatricial pemphigoid, the antibodies are directed against the anchoring filaments located beneath the epidermis.

Bullous Pemphigoid mucous membranes. constitutes a skin disease characterized by the formation of these large, tense blisters. If you need additional information on the pathogenesis and clinical presentation of this specific form of pemphigoid, we recommend consulting specialized resources.

It is a chronic, autoimmune, subepidermal blistering disease that can involve the.

mucous membranes. It is by far the most common autoimmune blistering disease and predominantly affects older people, although it can manifest at any age, including during childhood. Men and women of all ethnicities are equally susceptible.

The skin involvement in bullous pemphigoid can be extensive, but oral involvement is usually less pronounced, presenting small blisters that, while they rupture easily, do not do so as rapidly as those of pemphigus.

The therapeutic regimen is determined by the extent and severity of skin and mucous membrane involvement.

• Systemic topical
• Most patients are treated with systemic corticosteroids at adjustable doses.
• A biopsy may reveal deposits of
• Cyclophosphamide

Acquired Bullous Epidermolysis (ABE)

Treatment may also incorporate the following: ulcers.

Topical steroids recurring Tetracycline combined with nicotinamide.

Azathioprine

Cyclophosphamide Gestational Pemphigoid. Gestational pemphigoid (or pregnancy pemphigoid) is similar to bullous pemphigoid, differing in that it appears during gestation; it affects approximately between 1 in 10,000 and 1 in 60,000 pregnancies. It is also known as herpes gestationis. Small oral vesicles may arise, which can erode to cause.

ulcers. It is managed with systemic steroids and usually resolves once the baby is born; there is a possibility of recurrence in subsequent.

pregnancies.

The dermatosis , scabies, bullous disease Mucous Membrane Pemphigoid Mucous membrane pemphigoid, also called cicatricial pemphigoid, is an infrequent autoimmune blistering pathology affecting approximately one person per million. Generally, patients are middle-aged or older. It causes severe blisters in the oral cavity and on all mucous membranes, with the consequent development of scars. Ocular structures are particularly develop vulnerable.

. Skin involvement is minimal or nonexistent.

Rigorous therapy is required for cicatricial pemphigoid, including systemic steroids and immunosuppressive drugs, with cyclophosphamide being a key option.